rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
968.75   17.25   1.81%
Volume 143,024
Prev close 951.50
Day's H/L (Rs.) 972.00 - 955.00
52wk H/L (Rs.) 1,000.80 - 215.40
Mkt Cap (Rs. Cr) 28,239.06
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
968.45   16.50   1.73%
Volume 1,215,328
Prev close 951.95
Day's H/L (Rs.) 972.00 - 955.05
52wk H/L (Rs.) 1,002.30 - 215.10
Turnover (Rs. Lacs) 11,727.06
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 2,093 market voices)   

140 Characters
  Cancel
SHWETA SHARMA - 2 hour(s) ago BID OPPORTUNITIES IN STOCK MARKET AND THIS STOCK GIVE MAXIMUM RETURN, SEE NIFTY STOCK LIST 4 TRADE click on - http://rediff.ly/3q5n8 .......
#Aurobindo-Pharma-Ltd
Reply   |   Share
Sandeep Kumar Rajak - 15 hour(s) ago Intraday call Tgt 980sl 945
#Aurobindo-Pharma-Ltd
Reply   |   Share
PRATIK KAPADIA - 1 day ago  yess...
Reply   |  Share
PRATIK KAPADIA - 1 day ago  pakka hai na ...bro :)
Reply   |  Share
sandeep kumar - 15 hours ago  AUROPHARMA Stock Trend is in Neutral Downtrendso sometimes it fails to achieve its target ...but has more profitability in coming days -1 week
Reply   |  Share

Realtime news for Aurobindo Pharma Ltd. (See all 463 news)

31 October 2014, 23:20
Near term trading strategies for pharma stocks - 2 day(s) ago
Name YSR also as an accused: Aurobindo - 2 day(s) ago
Aurobindo Pharma allots equity shares - 07 Oct 2014
Aurobindo Pharma : UN BACKED BODY SUB-LICENSES HIV PRODUCT TO 5 INDIAN FIRMS - 30 Sep 2014
Lupin, Aurobindo and Mylan bags outstanding exports awards for 2013-14 - 25 Sep 2014

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 4 day(s) ago
Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 4 day(s) ago

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
23.91
EPS (Rs.)
40.21
Sales (Rs. Cr)
1,951.00
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
150
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Cadila Healthcare Ltd.
1,377.45
Torrent Pharmaceuticals Ltd.
864.80
Show more companies
Cadila Healthcare Ltd.
1,377.45
Torrent Pharmaceuticals Ltd.
864.80
Sanofi India Ltd.
3,318.80
Glenmark Pharmaceuticals Ltd.
714.45
Alembic Pharmaceuticals Ltd.
405.75
Dr. Reddy's Laboratories Ltd.
3,046.35
Natco Pharma Ltd.
1,388.10
Ajanta Pharma Ltd.
1,813.35
Lupin Ltd.
1,355.15
Ranbaxy Laboratories Ltd.
622.15
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close